Skip to content

The effects of umbilical cord squeezing in newborn babies requiring some form of intervention to help and support breathing at birth.

The effects of umbilical cord milking in neonates requiring resuscitation at birth: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/08/009484
Enrollment
236
Registered
2017-08-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Anemia in newborn

Interventions

Intervention1: UMBILICAL CORD MILKING GROUP(UCM): In the Umbilical cord milking group the cord will be milked thrice towards baby at a speed of 10 cm/s, and then clamped at 2-3 cm from umbilicus. Cont

Sponsors

Arpita
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Any neonate > 28 weeks gestation delivered in Obstetrics and Gynaecology department, KGMU requiring resuscitation will be enrolled.

Exclusion criteria

Exclusion criteria: Antenatally detected major congenital anomalies Cord prolapse Placenta previa or development of placental abruption Hydrops Umbilical cord abnormalities like true knot Refusal by the Obstetrician

Design outcomes

Primary

MeasureTime frame
haemoglobin and Hct Timepoint: at birth and 6 weeks of age

Secondary

MeasureTime frame
apgar scoresTimepoint: at birth;chronic lung diseaseTimepoint: during hospitalisation and follow up;hematocritTimepoint: at 6 hrs and 24 hours of life;hyperkalemiaTimepoint: during hospitalisation;mean arterial pressuresTimepoint: at 6 hrs and 24 hrs of life;mortalityTimepoint: during hospitalisation;necrotising enterocolitisTimepoint: during hospitalisation;need for ionotropesTimepoint: in the first 48 to 72 hrs;need for transfusionTimepoint: during hospitalisation and follow up;neurodevelopmental outcomeTimepoint: at 6 and 12 months of corrected age;patent ductus arteriosus Timepoint: during hospitalisation;peak jaundiceTimepoint: during hospitalisation;periventricular leukomalaciaTimepoint: during hospitalisation and follow up;requirement of phototherapy and exchange transfusionTimepoint: during hospitalisation;respiratory distress syndromeTimepoint: during hospitalisation;resuscitation requiredTimepoint: at birth;retinopathy of prematurityTimepoint: during hospitalisation and follow up;sepsisTimepoint: during hospitalisation;severe intraventricular haemorrhageTimepoint: during hospitalisation;time in days from birth to transfusionTimepoint: during hospitalisation and follow up;total volume of red cells transfusedTimepoint: in first 28 days of life;umblical cord pHTimepoint: at birth

Countries

India

Contacts

Public ContactArpita Bhriguvanshi

King Georges Medical University

arpime84@gmail.com7376865064

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026